FDA approves Aprecia’s 3D-printed anti-epileptic Spritam NABP report urges Internet drug website accountability NACDS: Collaboration essential to address drug abuse, preserve access GAO IDs 3 ways DEA can improve communications with pharmacists, manufacturers FDA approves Praluent, first PCSK9 inhibitor FDA approves new treatment for hepatitis C genotype 3 infections Upsher-Smith’s Androxy available after API manufacturer switch Dutch foundation exercises full call option on Mylan shares Novartis gets FDA approval for Odomzo FDA approves Technivie for chronic hepatitis C treatment First Previous 125 126 127 128 129 Next Last
